At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antidepressants
- Mechanism of Action Serotonin 1D receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 30 Nov 2000 No-Development-Reported for Depression in United Kingdom (Unknown route)
- 03 Jan 1997 Preclinical development for Depression in United Kingdom (Unknown route)